P

Precigen
D

PGEN

1.43000
USD
-0.1
(-6.54%)
Market Closed
Volume
7,642
EPS
0
Div Yield
0
P/E
-2
Market Cap
238,005,724
OverviewSignalsIdeasNews
Related Instruments
    A
    ALLO
    -0.21500
    (-7.29%)
    2.73500 USD
    A
    ARDX
    -0.02500
    (-0.45%)
    5.52500 USD
    B
    BTAI
    -0.09000
    (-8.04%)
    1.03000 USD
    C
    CRBP
    -0.500
    (-0.84%)
    59.160 USD
    C
    CRIS
    -0.60000
    (-11.05%)
    4.83000 USD
    R
    RVNC
    -0.41500
    (-10.99%)
    3.36000 USD
    V
    VKTX
    -2.380
    (-4.18%)
    54.610 USD
News

Title: Precigen

Sector: Healthcare
Industry: Biotechnology
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improvedproducts and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.